Search clinical trials for: CD23

Total 4 results

Boston Children's Hospital
TechLab, Incorporate

Completed

Study to Identify Non-Invasive Markers of Gastrointestinal Allergy

Esophagitis | Colitis

United States
Biogen

Terminated

Evaluation of Safety and Efficacy of Fludarabine, Cyclophosphamide, and Rituximab (FCR) +/- Lumiliximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

France, United States, Belgium, Australia, Austria, Poland, Canada, United Kingdom
Biogen

Terminated

Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL) (LUCID)

Chronic Lymphocytic Leukemia

United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Lithuania, Poland, Romania, Australia, Argentina, Austria, Canada, France, Israel, New Zealand, Portugal, Slovakia, Greece, Germany, India, Bel...
University of Mississippi Medical Center
Novartis Pharmaceuticals

Terminated

Soluble CD23 Expression in Asthma Patients Treated With OMA

Asthma

United States

3

Subscribe